超声造影应用于诊断膀胱良恶性肿瘤的研究进展

doi:10.3969/j.issn.1674-8115.2021.03.020

摘要/Abstract

摘要：

膀胱癌是全球第九大癌症，也是我国最常见的泌尿系统恶性肿瘤。膀胱癌起源于膀胱黏膜上皮，恶性程度高、易复发，以尿路上皮癌最为多见。膀胱良性肿瘤较少见，早期手术治疗效果好。膀胱肿瘤治疗方案的选择和患者的预后取决于肿瘤的早期发现和正确诊断。超声造影（contrast-enhanced ultrasound，CEUS）是一种实时动态显示微循环的影像学检查技术，具有安全性好、操作相对简便、可重复进行的优点。此技术在膀胱肿瘤的鉴别诊断以及膀胱癌的分期、分级评估中发挥越来越重要的作用。该文就CEUS应用于诊断膀胱肿瘤的研究进展进行综述。

关键词: 超声造影, 膀胱肿瘤, 鉴别诊断, 良性病变, 尿路上皮癌

Abstract:

Bladder cancer is the ninth leading cancer in the world, and the most common malignant tumor in urinary system in China. Bladder cancer is originated from mucosal epithelium of the bladder, has a high degree of malignancy and is easy to relapse. Urothelial carcinoma is the most common type. Benign bladder tumor is rare, and surgical removal yields better results. The optimal treatment and patients' prognosis of bladder tumor are attributed to its early detection and accurate diagnosis. Contrast-enhanced ultrasound (CEUS) is a new imaging technique which could dynamically display the microcirculation of tumors and tissues. The advantage of CEUS is good safety, easy manipulation, and repeatable use. CEUS is now playing a more and more significant role in diagnosing bladder tumors. In this article, the application of CEUS to the diagnosis of benign and malignant bladder tumors is reviewed.

Key words: contrast-enhanced ultrasound (CEUS), bladder tumor, differential diagnosis, benign lesion, urothelial carcinoma

中图分类号:

R445.1

于洁, 李凡. 超声造影应用于诊断膀胱良恶性肿瘤的研究进展[J]. 上海交通大学学报(医学版), 2021, 41(3): 396-399.

Jie YU, Fan LI. Research progress of contrast-enhanced ultrasound in the diagnosis of benign and malignant bladder tumors[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(3): 396-399.

参考文献 37

1	Mulvana H, Browning RJ, Luan Y, et al. Characterization of contrast agent microbubbles for ultrasound imaging and therapy research[J]. IEEE Trans Ultrason Ferroelectr Freq Control, 2017, 64(1): 232-251.
2	Wang SY, Hossack JA, Klibanov AL. Targeting of microbubbles: contrast agents for ultrasound molecular imaging[J]. J Drug Target, 2018, 26(5/6): 420-434.
3	Srivastava A, Douglass LM, Chernyak V, et al. Advances in imaging in prostate and bladder cancer[J]. Curr Urol Rep, 2017, 18(9): 69.
4	Pang EHT, Chan A, Ho SG, et al. Contrast-enhanced ultrasound of the liver: optimizing technique and clinical applications[J]. AJR Am J Roentgenol, 2018, 210(2): 320-332.
5	Wu HP, Abenojar EC, Perera R, et al. Time-intensity-curve analysis and tumor extravasation of nanobubble ultrasound contrast agents[J]. Ultrasound Med Biol, 2019, 45(9): 2502-2514.
6	Mu J, Mao YR, Li FX, et al. Superb microvascular imaging is a rational choice for accurate Bosniak classification of renal cystic masses[J]. Br J Radiol, 2019, 92(1099): 20181038.
7	Artul S, Nseir W, Armaly Z, et al. Superb microvascular imaging: added value and novel applications[J]. J Clin Imaging Sci, 2017, 7: 45.
8	Ayaz E, Ayaz M, Önal C, et al. Seeing the unseen: evaluating testicular vascularity in neonates by using the superb microvascular imaging ultrasound technique[J]. J Ultrasound Med, 2019, 38(7): 1847-1854.
9	Mao YR, Mu J, Zhao J, et al. The value of superb microvascular imaging in differentiating benign renal mass from malignant renal tumor: a retrospective study[J]. Br J Radiol, 2018, 91(1082): 20170601.
10	刘启平, 陈红燕, 朱慧, 等. 超微血管显像与超声造影在诊断膀胱占位性病变中的临床价值[J]. 肿瘤影像学, 2018, 27(6): 466-470.
11	刘启平, 王燕, 陈红燕. 超微血管显像技术对膀胱占位性病变的诊断价值[J]. 中国临床医学影像杂志, 2017, 28(12): 869-871, 880.
12	Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS [J]. Ultrasound Med Biol, 2013, 39(2): 187-210.
13	杜联芳, 李凡, 周洋, 等. 膀胱实性占位性病变的超声造影研究[J]. 中华超声影像学杂志, 2007, 16(10): 880-882.
14	Nicolau C, Bunesch L, Peri L, et al. Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer[J]. Br J Radiol, 2011, 84(1008): 1091-1099.
15	杜联芳, 李凡, 伍瑛, 等. 膀胱容量与声诺维超声造影[J]. 山西医药杂志, 2008, 37(9): 774-775.
16	Spiess PE, Agarwal N, Bangs R, et al. Bladder cancer, version 5. 2017, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2017, 15(10): 1240-1267.
17	Flaig TW, Spiess PE, Agarwal N, et al. NCCN guidelines insights: bladder cancer, version 5.2018[J]. J Natl Compr Canc Netw, 2018, 16(9): 1041-1053.
18	Amin MB. AJCC cancer staging manual[M]. 8th ed. Switzerland: Springer Press, 2017: 757‐765.
19	Tadin T, Sotosek S, Rahelić D, et al. Diagnostic accuracy of ultrasound T-staging of the urinary bladder cancer in comparison with histology in elderly patients[J]. Coll Antropol, 2014, 38(4): 1123-1126.
20	Caruso G, Salvaggio G, Campisi A, et al. Bladder tumor staging: comparison of contrast-enhanced and gray-scale ultrasound[J]. AJR Am J Roentgenol, 2010, 194(1): 151-156.
21	杜联芳, 周洋, 李凡, 等. 超声造影判断膀胱癌浸润程度及分期[J]. 中国医学影像技术, 2007, 23(12): 1853-1855.
22	Gupta VG, Kumar S, Singh SK, et al. Contrast enhanced ultrasound in urothelial carcinoma of urinary bladder: an underutilized staging and grading modality[J]. Cent European J Urol, 2016, 69(4): 360-365.
23	Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis[J]. Urology, 2005, 66(6 ): 4-34.
24	Lee CH, Tan CH, Faria SC, et al. Role of imaging in the local staging of urothelial carcinoma of the bladder[J]. AJR Am J Roentgenol, 2017, 208(6): 1193-1205.
25	Schlütermann D, Skowron MA, Berleth N, et al. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class Ⅲ PtdIns3K complex[J]. Urol Oncol, 2018, 36(4): 160.e1-160.e13.
26	Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary[J]. Int J Surg Pathol, 2005, 13(2): 143-153.
27	Li QY, Tang J, He EH, et al. Differentiation between high- and low-grade urothelial carcinomas using contrast enhanced ultrasound[J]. Oncotarget, 2017, 8(41): 70883-70889.
28	Guo SP, Xu P, Zhou AY, et al. Contrast-enhanced ultrasound differentiation between low- and high-grade bladder urothelial carcinoma and correlation with tumor microvessel density[J]. J Ultrasound Med, 2017, 36(11): 2287-2297.
29	丁凌, 胡兵. 膀胱内翻性乳头状瘤误诊为膀胱癌1例[J]. 中国超声医学杂志, 2014, 30(1): 68.
30	郭素萍, 周爱云, 徐盼, 等. 常规超声联合超声造影鉴别膀胱内翻性乳头状瘤与膀胱尿路上皮癌[J]. 中国超声医学杂志, 2017, 33(1): 54-56.
31	郭素萍, 周爱云, 徐盼, 等. 膀胱内翻性乳头状瘤和膀胱尿路上皮癌CEUS与微血管密度的相关性[J]. 中国医学影像技术, 2017, 33(5): 756-759.
32	杨帆, 吴火林, 陈媛, 等. 膀胱内翻性乳头状瘤与尿路上皮癌的超声特征比较[J]. 中国超声医学杂志, 2019, 35(1): 52-55.
33	叶琴, 林礼务, 薛恩生, 等. 彩色多普勒超声对腺性膀胱炎的鉴别诊断价值[J]. 中华超声影像学杂志, 2010(3): 248-250.
34	Mylarappa P, Puvvada S, Ramesh D. Benign glandular lesions of urinary bladder: diagnostic dilemma and clinical significance[J]. J Clin Diagn Res, 2019, 13(11): PC09-PC12.
35	Drudi FM, Di Candio G, Di Leo N, et al. Contrast-enhanced ultrasonography in the diagnosis of upper urinary tract urothelial cell carcinoma: a preliminary study[J]. Ultraschall Med, 2013, 34(1): 30-37.
36	Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version)[J]. Ultraschall Med, 2018, 39(2): e2-e44.
37	Xue LY, Lu Q, Huang BJ, et al. Evaluation of renal urothelial carcinoma by contrast-enhanced ultrasonography[J]. Eur J Radiol, 2013, 82(4): e151-e157.

[1]	王媚瑜1, 2，张一峰2, 3，陈捷1，郑丽1. 超声造影定量分析技术在乳腺导管内病变良恶性鉴别中的应用价值[J]. 上海交通大学学报（医学版）, 2020, 40(4): 514-.
[2]	李春晓，李　凡，白　敏，李　鑫，邵思惠. 肾上腺皮质腺瘤和皮质增生结节的超声造影特征分析[J]. 上海交通大学学报（医学版）, 2019, 39(4): 416-.
[3]	许开宇 1，魏玉虾 2，王大业 3，孙萍萍 3，周全 3，丁磊 1. 多发性恶性血管球瘤 1例临床病理分析[J]. 上海交通大学学报（医学版）, 2018, 38(12): 1499-.
[4]	李朝军,李万斌,白云,杨青,杜联芳,罗向红 . 急性大动脉粥样硬化性脑卒中患者颈动脉斑块超声造影定量指标与循环血白细胞的关系[J]. 上海交通大学学报（医学版）, 2017, 37(12): 1640-.
[5]	张时君，杜晶，吕仁华，田汝辉，李凤华. 非梗阻性无精子症患者睾丸局部生精功能的超声造影评估[J]. 上海交通大学学报（医学版）, 2017, 37(10): 1368-.
[6]	李晓钰，杜晶，杨仕平，等. 携抗HER2抗体和抗VEGFR2抗体聚乳酸羟基乙酸双靶向纳米高分子超声造影剂制备及体外实验研究[J]. 上海交通大学学报（医学版）, 2016, 36(01): 23-.
[7]	李艺，王燕，常婷，等. 经皮超声造影提示前哨淋巴结性质对腋窝淋巴结良恶性评估的价值[J]. 上海交通大学学报（医学版）, 2015, 35(9): 1320-.
[8]	王翠薇，杜晶，杨仕平，等. 携抗VEGFR2抗体PLGA靶向超声造影剂的制备及体外寻靶实验[J]. 上海交通大学学报（医学版）, 2014, 34(6): 772-.
[9]	朱昱思, 朱秀丽, 丁晶. 超声造影在原发性肝癌经导管动脉化学栓塞术疗效评价中的应用[J]. , 2013, 33(5): 694-.
[10]	沈海波, 曾彦恺, 顾正勤, 等. 再次经尿道电切术治疗非肌层浸润性膀胱尿路上皮癌临床分析[J]. , 2012, 32(4): 491-.
[11]	刘振华, 陈林, 詹维伟, 等. 睾丸扭转超声造影环状增强机制的实验研究[J]. , 2011, 31(2): 173-.
[12]	李殿城, 朱家安, 郭微, 等. 可携基因超声造影剂的制备及其体内外显影效果[J]. , 2010, 30(9): 1024-.
[13]	姚洁洁, 詹维伟, 陈曼, 等. 超声造影定量评价兔肾缺血再灌注损伤[J]. , 2010, 30(4): 428-.
[14]	杜光烨, 李小强, 刘立伟, 等. Cytokeratin 19、HBME-1和Galectin-3在甲状腺乳头状癌诊断中的应用[J]. , 2010, 30(4): 448-.
[15]	吴春华, 李凤华, 方华, 等. 超声造影在胰腺癌可切除性评估中的价值[J]. , 2010, 30(10): 1217-.